Vitamin D status and the risk of cardiovascular disease death

American Journal of Epidemiology

Volumn 170, Issue 8, 2009, Pages 1032-1039

  Kilkkinen, Annamari ^a   Knekt, Paul ^a   Aro, Antti ^a   Rissanen, Harri ^a   Marniemi, Jukka ^a   Heliövaara, Markku ^a   Impivaara, Olli ^a   Reunanen, Antti ^a  

^a NATIONAL PUBLIC HEALTH INSTITUTE   (Finland)

Author keywords

Cardiovascular diseases; Cohort studies; Mortality; Vitamin D

Indexed keywords

25 HYDROXYVITAMIN D;

CARDIOVASCULAR DISEASE; DISEASE SEVERITY; HEALTH RISK; HEALTH SURVEY; MORTALITY RISK; SERUM; VITAMIN;

ADULT; ARTICLE; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CEREBROVASCULAR DISEASE; CORONARY ARTERY DISEASE; FEMALE; FOLLOW UP; HEALTH SURVEY; HUMAN; MAJOR CLINICAL STUDY; MALE; MORTALITY; VITAMIN BLOOD LEVEL;

ADULT; CARDIOVASCULAR DISEASES; CEREBROVASCULAR DISORDERS; FEMALE; FINLAND; HUMANS; MALE; MIDDLE AGED; PROPORTIONAL HAZARDS MODELS; RISK FACTORS; VITAMIN D; VITAMIN D DEFICIENCY;

EID: 70349678964     PISSN: 00029262     EISSN: 14766256     Source Type: Journal    
DOI: 10.1093/aje/kwp227     Document Type: Article

References (35)

1. Holick MF. Vitamin D deficiency. N Engl J Med. 2007;357(3): 266-281.
2. Michos ED, Melamed ML. Vitamin D and cardiovascular disease risk. Curr Opin Clin Nutr Metab Care. 2008;11(1): 7-12.
3. Aihara K, Azuma H, Akaike M, et al. Disruption of nuclear vitamin D receptor gene causes enhanced thrombogenicity in mice. J Biol Chem. 2004;279(34):35798-35802.
4. Li YC, Kong J, Wei M, et al. 1,25-Dihydroxyvitamin D(3) is a negative endocrine regulator of the renin-angiotensin system. J Clin Invest. 2002;110(2):229-238.
5. Merke J, HofmannW, Goldschmidt D, et al. Demonstration of 1,25(OH)2 vitamin D3 receptors and actions in vascular smooth muscle cells in vitro. Calcif Tissue Int. 1987;41(2): 112-114.
6. Rigby WF, Denome S, Fanger MW. Regulation of lymphokine production and human T lymphocyte activation by 1,25- dihydroxyvitamin D3. Specific inhibition at the level of messenger RNA. J Clin Invest. 1987;79(6):1659-1664.
7. Poole KE, Loveridge N, Barker PJ, et al. Reduced vitamin D in acute stroke. Stroke. 2006;37(1):243-245.
8. Scragg R, Jackson R, Holdaway IM, et al.Myocardial infarction is inversely associated with plasma 25-hydroxyvitamin D3 levels: A community-based study. Int J Epidemiol. 1990;19(3): 559-563.
9. Zittermann A, Schleithoff SS, Koerfer R. Putting cardiovascular disease and vitamin D insufficiency into perspective. Br J Nutr. 2005;94(4):483-492.
10. Zittermann A, Schleithoff SS, Tenderich G, et al. Low vitamin D status: A contributing factor in the pathogenesis of congestive heart failure? J Am Coll Cardiol. 2003;41(1):105-112.
11. Martins D, Wolf M, Pan D, et al. Prevalence of cardiovascular risk factors and the serum levels of 25-hydroxyvitamin D in the United States: data from the Third National Health and Nutrition Examination Survey. Arch Intern Med. 2007;167(11): 1159-1165.
12. Kendrick J, Targher G, Smits G, et al. 25-Hydroxyvitamin D deficiency is independently associated with cardiovascular disease in the Third National Health and Nutrition Examination Survey. Atherosclerosis. 2009;205(1):255-260.
13. Dobnig H, Pilz S, Scharnagl H, et al. Independent association of low serum 25-hydroxyvitamin D and 1,25-dihydroxyvitamin D levels with all-cause and cardiovascular mortality. Arch Intern Med. 2008;168(12):1340-1349.
14. Giovannucci E, Liu Y, Hollis BW, et al. 25-hydroxyvitamin D and risk of myocardial infarction in men: A prospective study. Arch Intern Med. 2008;168(11):1174-1180.
15. Wang TJ, Pencina MJ, Booth SL, et al. Vitamin D deficiency and risk of cardiovascular disease. Circulation. 2008;117(4): 503-511.
16. Melamed ML, Michos ED, Post W, et al. 25-Hydroxyvitamin D levels and the risk of mortality in the general population. Arch Intern Med. 2008;168(15):1629-1637.
17. Hsia J, Heiss G, Ren H, et al. Calcium/vitamin D supplementation and cardiovascular events. Circulation. 2007;115(7): 846-854.
18. Neuhouser ML, Wassertheil-Smoller S, Thomson C, et al. Multivitamin use and risk of cancer and cardiovascular disease in the Women's Health Initiative cohorts. Arch Intern Med. 2009;169(3):294-304.
19. Aromaa A, Heliovaara M, Impivaara O, et al. The Execution of Mini-Finland Health Survey: Aims, Methods, and Study Population [in Finnish with English summary]. (Publication no. ML:88). Helsinki, Finland: Social Insurance Institution; 1989.
20. Carr JJ, Drekter IJ. Simplified rapid technic for the extraction and determination of serum cholesterol without saponification. Clin Chem. 1956;2(5):353-368
21. Kannel WB, D'Agostino RB, Sullivan L, et al. Concept and usefulness of cardiovascular risk profiles. Am Heart J. 2004; 148(1):16-26.
22. Watson KE, Abrolat ML, Malone LL, et al. Active serum vitamin D levels are inversely correlated with coronary calcification. Circulation. 1997;96(6):1755-1760.
23. Jouni ZE, Winzerling JJ, McNamara DJ. 1,25-Dihydroxyvitamin D3-induced HL-60 macrophages: regulation of cholesterol and LDL metabolism. Atherosclerosis. 1995; 117(1):125-138.
24. Rostand SG, Drüeke TB. Parathyroid hormone, vitamin D, and cardiovascular disease in chronic renal failure. Kidney Int. 1999;56(2):383-392.
25. Tuohimaa P, Tenkanen L, Ahonen M, et al. Both high and low levels of blood vitamin D are associated with a higher prostate cancer risk: A longitudinal, nested case-control study in the Nordic countries. Int J Cancer. 2004;108(1):104-108.
26. Ovesen L, Andersen R, Jakobsen J. Geographical differences in vitamin D status, with particular reference to European countries. Proc Nutr Soc. 2003;62(4):813-821.
27. Bischoff-Ferrari HA, Giovannucci E, Willett WC, et al. Estimation of optimal serum concentrations of 25-hydroxyvitamin D for multiple health outcomes. Am J Clin Nutr. 2006;84(1): 18-28.
28. Mähönen M, Salomaa V, Torppa J, et al. The validity of the routine mortality statistics on coronary heart disease in Finland: comparison with the FINMONICA MI register data for the years 1983-1992. J Clin Epidemiol. 1999;52(2):157-166.
29. Pajunen P, Koukkunen H, Ketonen M, et al. The validity of the Finnish Hospital Discharge Register and Causes of Death Register data on coronary heart disease. Eur J Cardiovasc Prev Rehabil. 2005;12(2):132-137.
30. He K, Song Y, Daviglus ML, et al. Accumulated evidence on fish consumption and coronary heart disease mortality: A metaanalysis of cohort studies. Circulation. 2004;109(22): 2705-2711.
31. Hooper L, Thompson RL, Harrison RA, et al. Risks and benefits of omega 3 fats for mortality, cardiovascular disease, and cancer: systematic review. BMJ. 2006;332(7544):752-760.
32. Platz EA, Leitzmann MF, Hollis BW, et al. Plasma 1,25-dihydroxy- and 25-hydroxyvitamin D and subsequent risk of prostate cancer. Cancer Causes Control. 2004;15(3):255-265.
33. Lissner D, Mason RS, Posen S. Stability of vitamin D metabolites in human blood serum and plasma. Clin Chem. 1981; 27(5):773-774.
34. Ockè MC, Schrijver J, Obermann-de Boer GL, et al. Stability of blood (pro)vitamins during four years of storage at 20 degrees C: consequences for epidemiologic research. J Clin Epidemiol. 1995;48(8):1077-1085.
35. Hollis BW. Measuring 25-hydroxyvitamin D in a clinical environment: challenges and needs. Am J Clin Nutr. 2008; 88(suppl 2):507S-510S.